Clinical trial
The Optimization of Bioavailability From Iron Supplements: Examinations of Different Supplementation Regimens Including Hepcidin Profiles
NCT02177851 is registered in ClinicalTrials.gov with Swiss Federal Institute of Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optimization of Bioavailability From Iron Supplements: Examinations of Different Supplementation Regimens Including Hepcidin Profiles
- Lead sponsor
- Swiss Federal Institute of Technology
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- December 31, 2015
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anemia, iron deficiency, iron deficiency anemia